Pembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. TPS6094-TPS6094
◽
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):